Try our mobile app

General information

Country: CANADA

Sector: Drug Manufacturers — Specialty and Generic

Categories: @cannabis-players   

Tilray, Inc. operates as a pharmaceutical company. The Company develops cannabis based medicines, drugs, drops, and oil products. Tilray serves clients worldwide.
  • Current market environment: negative. Prices of production are 3.8% lower compared to the last 12 months (LTM)
  • Prices of production are at 9.9% percentile over the past 5 years, adjusted for inflation (are close to minimun)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 2.7% (LTM), projected 0.1%
  • Share price is 127.5% higher than minimum and 75.3% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (-1.8x vs
    )
  • The company is undervalued by EV / projected EBITDA multiple compared to target level (
    vs
    )

Key Financials (Download financials)

Ticker: TLRY
Share price, USD:  (+6.4%)8.19
year average price 8.54  


year start price 9.39 2025-02-11

min close price 3.60 2025-06-20

max close price 21.00 2025-10-09

current price 8.19 2026-02-10
Common stocks: 460 254 275

Dividend Yield:  0.0%
FCF Yield LTM / expected: 2.7% / 0.1%
EV / LTM EBITDA: -1.8x
Production prices change from LTM: -3.8%
EV / projected EBITDA:
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 3 769
Net Debt ($m): -14
EV (Enterprise Value): 3 755
EBITDA LTM ($m): -2 124
EV / LTM EBITDA: -1.8x
Price to Book: 2.5x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / LTM EBITDA and 75% percentile

Potential dynamics

News


2026-01-30zacks.com

TLRY vs. CGC: Which Cannabis Stock is the Better Investment Now?

2026-01-14zacks.com

What's Next for Tilray Brands After Posting Record Q2 Revenues?

2026-01-13zacks.com

Should You Buy, Sell or Hold TLRY Stock Post Q2 Earnings?

2025-12-24fool.com

This Stock Has Almost Tripled in 6 Months. Here's What Investors Need to Watch Next

2025-12-22zacks.com

Tilray Brands, Inc. (TLRY) Stock Falls Amid Market Uptick: What Investors Need to Know

2025-12-22globenewswire.com

Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026

2025-12-18youtube.com

TLRY Soars on Marijuana Reclassification Hopes, Burning Question Centers on Profits

2025-12-15zacks.com

Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today

2025-12-14fool.com

Why Tilray Stock Soared This Week

2025-12-12marketwatch.com

Tilray's stock takes off on hope that cannabis will soon be treated more like steroids than heroin
More information for subscribed users:
detailed calculation of Potential,
commodities and currency affecting the company